Trump Imposes 100% Tariff on Branded and Patented Pharma Imports

US President Donald Trump has announced a 100% tariff on branded and patented pharmaceutical drugs, effective from October 1, 2025. This move continues his push for tariffs to reduce the budget deficit and boost domestic manufacturing.

The decision is expected to impact the Indian pharma industry, as India is the largest exporter of pharmaceuticals to the US, with exports reaching $27.9 billion in FY2024 and $30 billion in FY2025.